Spektor Ekaterina, Fietze Ingo, Poluektov Mikhail G
Department of Sleep Medicine, Chair of Neurology and Neurosurgery, University Clinical Hospital No. 3, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Center of Sleep Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Front Neurol. 2021 Sep 27;12:700151. doi: 10.3389/fneur.2021.700151. eCollection 2021.
Cerebrovascular diseases are the leading cause of cognitive decline and dementia. Therefore, the investigation of the potential ways to slow down the disease progression is an important research field. Periodic limb movements in sleep (PLMS) are known to be associated with transient changes in heart rate and blood pressure. These changes might influence the course of cerebral small vessel disease (cSVD). Nevertheless, the clinical significance of PLMS, particularly its influence on cardiovascular diseases course, is still controversial and underinvestigated. Patients from 60 to 75 years old diagnosed with cSVD will undergo nocturnal polysomnography. Subjects with apnea/hypopnea index under 5 will be enrolled. Sleep quality and daytime functioning will be assessed at baseline with self-reported questionnaires. Brain MRI and cognitive assessment will be performed at baseline and in the 2-year follow-up. Progression of cSVD markers and cognitive dysfunction will be compared between patients with PLMS index (PLMI) equal to or more than 15 movements per hour of sleep and controls (PLMI <15/h). The negative role of PLMS in cSVD progression and related cognitive decline is expected. We suppose that patients with PLMS tend to worsen in cognitive performance more rapidly than age-, gender-, and comorbidity-matched controls. We also expect them to have more rapid white matter hyperintensities and other cSVD marker progression. The limitations of the study protocol are the short follow-up period, the absence of a treatment group, and inability to make a conclusion about causality.
脑血管疾病是认知衰退和痴呆的主要原因。因此,研究减缓疾病进展的潜在方法是一个重要的研究领域。已知睡眠期周期性肢体运动(PLMS)与心率和血压的短暂变化有关。这些变化可能会影响脑小血管疾病(cSVD)的病程。然而,PLMS的临床意义,尤其是其对心血管疾病病程的影响,仍存在争议且研究不足。60至75岁被诊断为cSVD的患者将接受夜间多导睡眠图检查。呼吸暂停/低通气指数低于5的受试者将被纳入研究。在基线时使用自我报告问卷评估睡眠质量和日间功能。在基线和2年随访时进行脑部MRI和认知评估。比较睡眠期周期性肢体运动指数(PLMI)等于或高于每小时睡眠15次的患者与对照组(PLMI<15/h)之间cSVD标志物的进展和认知功能障碍情况。预计PLMS在cSVD进展和相关认知衰退中起负面作用。我们推测,与年龄、性别和合并症相匹配的对照组相比,PLMS患者的认知表现恶化得更快。我们还预计他们的白质高信号和其他cSVD标志物进展更快。该研究方案的局限性在于随访期短、没有治疗组以及无法得出因果关系的结论。